Industry Research Reports
Home > Reports > Medical Devices & Consumables > Fusion Transcript Assays- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Fusion Transcript Assays- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 100 Pages
Report ld: 3496965
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Fusion Transcript Assays Market Size(US$)
CAGR 2025-2031
3.6%
Market Size,2031
USD 119
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 96 million
Market Forecast in 2031(Value)
US$ 119 million
CAGR
3.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Fusion Transcript Assays was estimated to be worth US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
North American market for Fusion Transcript Assays was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fusion Transcript Assays was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Fusion Transcript Assays was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Fusion Transcript Assays include Thermo Fisher Scientific, Illumina, Inc., Merck Millipore, Hologic Inc., Hologic Inc Bio-Rad Laboratories Inc., Caris Life Sciences, SeraCare Life Sciences Inc., QIAGEN, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Fusion Transcript Assays, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Fusion Transcript Assays by region & country, by Type, and by Application.
The Fusion Transcript Assays market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Transcript Assays.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Illumina, Inc.
- Merck Millipore
- Hologic Inc.
- Hologic Inc Bio-Rad Laboratories Inc.
- Caris Life Sciences
- SeraCare Life Sciences Inc.
- QIAGEN
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Fusion Transcript Kits
- PCR Devices
Segment by Application
- Hospital
- Cancer Research Center
- Diagnostic Laboratory
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fusion Transcript Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Fusion Transcript Assays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Fusion Transcript Assays in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fusion Transcript Assays Product Introduction
1.2 Global Fusion Transcript Assays Market Size Forecast (2020-2031)
1.3 Fusion Transcript Assays Market Trends & Drivers
1.3.1 Fusion Transcript Assays Industry Trends
1.3.2 Fusion Transcript Assays Market Drivers & Opportunity
1.3.3 Fusion Transcript Assays Market Challenges
1.3.4 Fusion Transcript Assays Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fusion Transcript Assays Players Revenue Ranking (2024)
2.2 Global Fusion Transcript Assays Revenue by Company (2020-2025)
2.3 Key Companies Fusion Transcript Assays Manufacturing Base Distribution and Headquarters
2.4 Key Companies Fusion Transcript Assays Product Offered
2.5 Key Companies Time to Begin Mass Production of Fusion Transcript Assays
2.6 Fusion Transcript Assays Market Competitive Analysis
2.6.1 Fusion Transcript Assays Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Fusion Transcript Assays Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Transcript Assays as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fusion Transcript Kits
3.1.2 PCR Devices
3.2 Global Fusion Transcript Assays Sales Value by Type
3.2.1 Global Fusion Transcript Assays Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Fusion Transcript Assays Sales Value, by Type (2020-2031)
3.2.3 Global Fusion Transcript Assays Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Cancer Research Center
4.1.3 Diagnostic Laboratory
4.1.4 Others
4.2 Global Fusion Transcript Assays Sales Value by Application
4.2.1 Global Fusion Transcript Assays Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Fusion Transcript Assays Sales Value, by Application (2020-2031)
4.2.3 Global Fusion Transcript Assays Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Fusion Transcript Assays Sales Value by Region
5.1.1 Global Fusion Transcript Assays Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Fusion Transcript Assays Sales Value by Region (2020-2025)
5.1.3 Global Fusion Transcript Assays Sales Value by Region (2026-2031)
5.1.4 Global Fusion Transcript Assays Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Fusion Transcript Assays Sales Value, 2020-2031
5.2.2 North America Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Fusion Transcript Assays Sales Value, 2020-2031
5.3.2 Europe Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Fusion Transcript Assays Sales Value, 2020-2031
5.4.2 Asia Pacific Fusion Transcript Assays Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Fusion Transcript Assays Sales Value, 2020-2031
5.5.2 South America Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Fusion Transcript Assays Sales Value, 2020-2031
5.6.2 Middle East & Africa Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fusion Transcript Assays Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Fusion Transcript Assays Sales Value, 2020-2031
6.3 United States
6.3.1 United States Fusion Transcript Assays Sales Value, 2020-2031
6.3.2 United States Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Fusion Transcript Assays Sales Value, 2020-2031
6.4.2 Europe Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Fusion Transcript Assays Sales Value, 2020-2031
6.5.2 China Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.5.3 China Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Fusion Transcript Assays Sales Value, 2020-2031
6.6.2 Japan Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Fusion Transcript Assays Sales Value, 2020-2031
6.7.2 South Korea Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Fusion Transcript Assays Sales Value, 2020-2031
6.8.2 Southeast Asia Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Fusion Transcript Assays Sales Value, 2020-2031
6.9.2 India Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
6.9.3 India Fusion Transcript Assays Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Fusion Transcript Assays Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina, Inc.
7.2.1 Illumina, Inc. Profile
7.2.2 Illumina, Inc. Main Business
7.2.3 Illumina, Inc. Fusion Transcript Assays Products, Services and Solutions
7.2.4 Illumina, Inc. Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.2.5 Illumina, Inc. Recent Developments
7.3 Merck Millipore
7.3.1 Merck Millipore Profile
7.3.2 Merck Millipore Main Business
7.3.3 Merck Millipore Fusion Transcript Assays Products, Services and Solutions
7.3.4 Merck Millipore Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.3.5 Merck Millipore Recent Developments
7.4 Hologic Inc.
7.4.1 Hologic Inc. Profile
7.4.2 Hologic Inc. Main Business
7.4.3 Hologic Inc. Fusion Transcript Assays Products, Services and Solutions
7.4.4 Hologic Inc. Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.4.5 Hologic Inc. Recent Developments
7.5 Hologic Inc Bio-Rad Laboratories Inc.
7.5.1 Hologic Inc Bio-Rad Laboratories Inc. Profile
7.5.2 Hologic Inc Bio-Rad Laboratories Inc. Main Business
7.5.3 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Products, Services and Solutions
7.5.4 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.5.5 Hologic Inc Bio-Rad Laboratories Inc. Recent Developments
7.6 Caris Life Sciences
7.6.1 Caris Life Sciences Profile
7.6.2 Caris Life Sciences Main Business
7.6.3 Caris Life Sciences Fusion Transcript Assays Products, Services and Solutions
7.6.4 Caris Life Sciences Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.6.5 Caris Life Sciences Recent Developments
7.7 SeraCare Life Sciences Inc.
7.7.1 SeraCare Life Sciences Inc. Profile
7.7.2 SeraCare Life Sciences Inc. Main Business
7.7.3 SeraCare Life Sciences Inc. Fusion Transcript Assays Products, Services and Solutions
7.7.4 SeraCare Life Sciences Inc. Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.7.5 SeraCare Life Sciences Inc. Recent Developments
7.8 QIAGEN
7.8.1 QIAGEN Profile
7.8.2 QIAGEN Main Business
7.8.3 QIAGEN Fusion Transcript Assays Products, Services and Solutions
7.8.4 QIAGEN Fusion Transcript Assays Revenue (US$ Million) & (2020-2025)
7.8.5 QIAGEN Recent Developments
8 Industry Chain Analysis
8.1 Fusion Transcript Assays Industrial Chain
8.2 Fusion Transcript Assays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fusion Transcript Assays Sales Model
8.5.2 Sales Channel
8.5.3 Fusion Transcript Assays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Fusion Transcript Assays Market Trends
Table 2. Fusion Transcript Assays Market Drivers & Opportunity
Table 3. Fusion Transcript Assays Market Challenges
Table 4. Fusion Transcript Assays Market Restraints
Table 5. Global Fusion Transcript Assays Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Fusion Transcript Assays Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Fusion Transcript Assays Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Fusion Transcript Assays Product Type
Table 9. Key Companies Time to Begin Mass Production of Fusion Transcript Assays
Table 10. Global Fusion Transcript Assays Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Transcript Assays as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Fusion Transcript Assays Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Fusion Transcript Assays Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Fusion Transcript Assays Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Fusion Transcript Assays Sales Market Share in Value by Type (2020-2025)
Table 17. Global Fusion Transcript Assays Sales Market Share in Value by Type (2026-2031)
Table 18. Global Fusion Transcript Assays Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Fusion Transcript Assays Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Fusion Transcript Assays Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Fusion Transcript Assays Sales Market Share in Value by Application (2020-2025)
Table 22. Global Fusion Transcript Assays Sales Market Share in Value by Application (2026-2031)
Table 23. Global Fusion Transcript Assays Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Fusion Transcript Assays Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Fusion Transcript Assays Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Fusion Transcript Assays Sales Value by Region (2020-2025) & (%)
Table 27. Global Fusion Transcript Assays Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Fusion Transcript Assays Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Fusion Transcript Assays Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Fusion Transcript Assays Sales Value, (2026-2031) & (US$ Million)
Table 31. Thermo Fisher Scientific Basic Information List
Table 32. Thermo Fisher Scientific Description and Business Overview
Table 33. Thermo Fisher Scientific Fusion Transcript Assays Products, Services and Solutions
Table 34. Revenue (US$ Million) in Fusion Transcript Assays Business of Thermo Fisher Scientific (2020-2025)
Table 35. Thermo Fisher Scientific Recent Developments
Table 36. Illumina, Inc. Basic Information List
Table 37. Illumina, Inc. Description and Business Overview
Table 38. Illumina, Inc. Fusion Transcript Assays Products, Services and Solutions
Table 39. Revenue (US$ Million) in Fusion Transcript Assays Business of Illumina, Inc. (2020-2025)
Table 40. Illumina, Inc. Recent Developments
Table 41. Merck Millipore Basic Information List
Table 42. Merck Millipore Description and Business Overview
Table 43. Merck Millipore Fusion Transcript Assays Products, Services and Solutions
Table 44. Revenue (US$ Million) in Fusion Transcript Assays Business of Merck Millipore (2020-2025)
Table 45. Merck Millipore Recent Developments
Table 46. Hologic Inc. Basic Information List
Table 47. Hologic Inc. Description and Business Overview
Table 48. Hologic Inc. Fusion Transcript Assays Products, Services and Solutions
Table 49. Revenue (US$ Million) in Fusion Transcript Assays Business of Hologic Inc. (2020-2025)
Table 50. Hologic Inc. Recent Developments
Table 51. Hologic Inc Bio-Rad Laboratories Inc. Basic Information List
Table 52. Hologic Inc Bio-Rad Laboratories Inc. Description and Business Overview
Table 53. Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Products, Services and Solutions
Table 54. Revenue (US$ Million) in Fusion Transcript Assays Business of Hologic Inc Bio-Rad Laboratories Inc. (2020-2025)
Table 55. Hologic Inc Bio-Rad Laboratories Inc. Recent Developments
Table 56. Caris Life Sciences Basic Information List
Table 57. Caris Life Sciences Description and Business Overview
Table 58. Caris Life Sciences Fusion Transcript Assays Products, Services and Solutions
Table 59. Revenue (US$ Million) in Fusion Transcript Assays Business of Caris Life Sciences (2020-2025)
Table 60. Caris Life Sciences Recent Developments
Table 61. SeraCare Life Sciences Inc. Basic Information List
Table 62. SeraCare Life Sciences Inc. Description and Business Overview
Table 63. SeraCare Life Sciences Inc. Fusion Transcript Assays Products, Services and Solutions
Table 64. Revenue (US$ Million) in Fusion Transcript Assays Business of SeraCare Life Sciences Inc. (2020-2025)
Table 65. SeraCare Life Sciences Inc. Recent Developments
Table 66. QIAGEN Basic Information List
Table 67. QIAGEN Description and Business Overview
Table 68. QIAGEN Fusion Transcript Assays Products, Services and Solutions
Table 69. Revenue (US$ Million) in Fusion Transcript Assays Business of QIAGEN (2020-2025)
Table 70. QIAGEN Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Fusion Transcript Assays Downstream Customers
Table 74. Fusion Transcript Assays Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Fusion Transcript Assays Product Picture
Figure 2. Global Fusion Transcript Assays Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Fusion Transcript Assays Sales Value (2020-2031) & (US$ Million)
Figure 4. Fusion Transcript Assays Report Years Considered
Figure 5. Global Fusion Transcript Assays Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Fusion Transcript Assays Revenue in 2024
Figure 7. Fusion Transcript Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Fusion Transcript Kits Picture
Figure 9. PCR Devices Picture
Figure 10. Global Fusion Transcript Assays Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Fusion Transcript Assays Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Cancer Research Center
Figure 14. Product Picture of Diagnostic Laboratory
Figure 15. Product Picture of Others
Figure 16. Global Fusion Transcript Assays Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Fusion Transcript Assays Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America Fusion Transcript Assays Sales Value (2020-2031) & (US$ Million)
Figure 19. North America Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific Fusion Transcript Assays Sales Value by Region (%), 2024 VS 2031
Figure 24. South America Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa Fusion Transcript Assays Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions Fusion Transcript Assays Sales Value (%), (2020-2031)
Figure 29. United States Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 31. United States Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 35. China Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 36. China Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 37. China Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 47. India Fusion Transcript Assays Sales Value, (2020-2031) & (US$ Million)
Figure 48. India Fusion Transcript Assays Sales Value by Type (%), 2024 VS 2031
Figure 49. India Fusion Transcript Assays Sales Value by Application (%), 2024 VS 2031
Figure 50. Fusion Transcript Assays Industrial Chain
Figure 51. Fusion Transcript Assays Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 3.6% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Fusion Transcript Assays market?
What was the global market size of Fusion Transcript Assays in 2031?
What is the annual compound growth rate of the global Fusion Transcript Assays market size from 2025 to 2031?
What was the global market size of Fusion Transcript Assays in 2025?
Related Reports
Fusion Transcript Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fusion Transcript Assays was estimated to be worth US$ 96 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 106
USD 3950.00
(Single User License)
Global Fusion Transcript Assays Market Research Report 2026
The global Fusion Transcript Assays market was valued at US$ 96 million in 2025 and is anticipated to reach US$ 123 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 107
USD 2900.00
(Single User License)
Global Fusion Transcript Assays Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fusion Transcript Assays market size was US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
Global Fusion Transcript Assays Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Fusion Transcript Assays market is projected to grow from US$ 93 million in 2024 to US$ 119 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 117
USD 4900.00
(Single User License)
Global Fusion Transcript Assays Market Research Report 2025
The global market for Fusion Transcript Assays was valued at US$ 93 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-01-13
Pages: 73
USD 2900.00
(Single User License)
Fusion Transcript Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Fusion Transcript Assays was estimated to be worth US$ 96 million in 2025 and is projected to reach US$ 123 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-06-16
Pages: 106
USD 3950.00 (Single User License)Global Fusion Transcript Assays Market Research Report 2026
The global Fusion Transcript Assays market was valued at US$ 96 million in 2025 and is anticipated to reach US$ 123 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 107
USD 2900.00 (Single User License)Global Fusion Transcript Assays Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Fusion Transcript Assays market size was US$ 93 million in 2024 and is forecast to a readjusted size of US$ 119 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
USD 4250.00 (Single User License)Global Fusion Transcript Assays Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Fusion Transcript Assays market is projected to grow from US$ 93 million in 2024 to US$ 119 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 117
USD 4900.00 (Single User License)Global Fusion Transcript Assays Market Research Report 2025
The global market for Fusion Transcript Assays was valued at US$ 93 million in the year 2024 and is projected to reach a revised size of US$ 119 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-01-13
Pages: 73
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now